TRVI Trevi Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Visualizza su SEC EDGAR ↗ chiudi Ott 5, 2026 10-K/10-Q Ago 6, 2026
$13,78
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$9,28minimo 52 sett.
$20,22massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$1.96B
P/E
-43.1
EPS
$-0.32
i tuoi badge
Intervallo 52 sett.
$9–$20
Rating Analisti
BUY
Prezzo Obiettivo
$28
P/E
-43.1
ROE
-22.4%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
TRVI Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$13.78
Capitalizzazione di Mercato (MRQ)
$1.96B
P/E
-43.1
EPS
$-0.32
ROE
-22.4%
Intervallo 52 sett.
$9–$20
TRVI Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
EPS$-0.322021-12-31 → 2025-12-31
Flusso di cassa libero$-42M2019-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | TRVI | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -43.1media 5 anni ≈-11.5 | ≈-11.5 | · | · | |
| P/B (MRQ) | 6.1media 5 anni ≈3.2 | ≈3.2 | 4.0 | Sopravvalutato | |
| Prezzo / FCF (TTM) | -37.1media 5 anni ≈-13.8 | ≈-13.8 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -37.3media 5 anni ≈-11.2 | ≈-11.2 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 9.6media 5 anni ≈3.2 | ≈3.2 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | TRVI | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -28.1%media 5 anni ≈-43.7% | ≈-43.7% | -6.8% | Debole | |
| ROE | -22.4%media 5 anni ≈-76.4% | ≈-76.4% | -11.4% | Debole | |
| ROIC | -26.9%media 5 anni ≈-67.5% | ≈-67.5% | -16.0% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | TRVI | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 37.3media 5 anni ≈11.4 | ≈11.4 | 5.5 | Liquidità elevata | |
| Quick Ratio | 19.3media 5 anni ≈11.1 | ≈11.1 | 4.2 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
13.7%
Prossimo report
Nov 11, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 5, 2026 | $-0.11 | $-0.11 | 2.2% |
| 31 Marzo 2026 | $-0.09 | $-0.08 | -15.4% | |
| 31 Dicembre 2025 | $-0.06 | $-0.10 | 40.1% | |
| 30 Settembre 2025 | $-0.08 | $-0.10 | 20.2% | |
| 30 Giugno 2025 | $-0.09 | $-0.10 | 12.6% | |
| 31 Marzo 2025 | $-0.09 | $-0.12 | 27.1% | |
| 31 Dicembre 2024 | $-0.11 | $-0.12 | 9.3% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $33M | $39M | $24M | $20M | $23M | $22M | $19M | $14M | |
| SG&A Expense | $16M | $12M | $10M | $10M | $9M | $10M | $7M | $4M | |
| Operating Expenses | $49M | $52M | $34M | $30M | $32M | $32M | $27M | $18M | |
| Operating Income | $-49M | $-52M | $-34M | $-30M | $-32M | $-32M | $-27M | $-18M | |
| Interest Expense | · | · | $391.0K | $1M | $1M | $456.0K | · | $174.0K | |
| Interest Income | $7M | $4M | $5M | · | · | · | · | · | |
| Other Non-op | $-31.0K | $-15.0K | $469.0K | $289.0K | $-375.0K | $-287.0K | $577.0K | $-2M | |
| Pretax Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| Income Tax | $-64.0K | $-30.0K | $-32.0K | $-36.0K | $-21.0K | $-18.0K | $-18.0K | $-124.0K | |
| Net Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| EPS (Basic) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| EPS (Diluted) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| Shares (Basic) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| Shares (Diluted) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| EBITDA | $-49M | $-51M | $-34M | $-30M | $-32M | $-32M | $-27M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $34M | $32M | $13M | $37M | $45M | $57M | $7M | |
| Short-term Investments | $169M | $74M | $51M | $108M | · | · | · | · | |
| Prepaid Expense | $1M | $939.0K | $4M | $795.0K | $886.0K | $1M | $2M | $1M | |
| Other Current Assets | $2M | $867.0K | $955.0K | $1M | $241.0K | $265.0K | · | · | |
| Current Assets | $192M | $109M | $88M | $123M | $38M | $46M | $60M | $9M | |
| PP&E (Net) | $178.0K | $157.0K | $216.0K | $170.0K | $53.0K | $103.0K | $118.0K | $149.0K | |
| PP&E (Gross) | $537.0K | $385.0K | $350.0K | $395.0K | $235.0K | $235.0K | $203.0K | $195.0K | |
| Accum. Depreciation | $359.0K | $228.0K | $134.0K | $225.0K | $182.0K | $132.0K | $85.0K | $46.0K | |
| Other Non-current Assets | $928.0K | $243.0K | $297.0K | $205.0K | $334.0K | $532.0K | · | · | |
| Total Assets | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Accounts Payable | $4M | $3M | $2M | $3M | $3M | $2M | $2M | $603.0K | |
| Accrued Liabilities | $6M | $7M | $4M | $4M | $4M | $3M | $4M | $2M | |
| Current Liabilities | $10M | $11M | $6M | $13M | $13M | $6M | $5M | $3M | |
| Capital Leases | $446.0K | $747.0K | $1M | $2.0K | $24.0K | $144.0K | $257.0K | $46.0K | |
| Other Non-current Liabilities | · | · | · | $3.0K | · | · | · | · | |
| Total Liabilities | $10M | $11M | $7M | $16M | $21M | $20M | · | · | |
| Common Stock | $128.0K | $94.0K | $68.0K | $60.0K | $29.0K | $19.0K | $18.0K | $4.0K | |
| Paid-in Capital | $513M | $387M | $322M | $318M | $198M | $174M | $169M | · | |
| Retained Earnings | $-330M | $-287M | $-239M | $-210M | $-181M | $-147M | $-114M | $-109M | |
| AOCI | $148.0K | $61.0K | $-29.0K | $-122.0K | · | · | · | · | |
| Stockholders' Equity | $183M | $100M | $83M | $107M | $17M | $27M | $55M | $-109M | |
| Liabilities + Equity | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Shares Outstanding | 128,306,056 | 93,602,631 | 68,283,699 | 59,943,430 | 28,505,804 | 18,546,786 | 17,834,570 | 438,600 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $144.0K | $147.0K | $123.0K | $43.0K | · | · | · | · | |
| Stock-based Comp | $5M | $4M | $2M | $2M | $3M | $2M | $1M | $496.0K | |
| Other Non-cash | $-5M | $6M | $-5M | · | · | · | · | · | |
| Operating Cash Flow | $-42M | $-38M | $-32M | $-28M | $-29M | $-29M | $-23M | $-18M | |
| CapEx | $12.0K | $35.0K | $137.0K | $159.0K | · | $32.0K | $9.0K | $158.0K | |
| Investing Cash Flow | $-94M | $-22M | $59M | $-107M | · | $-32.0K | $-9.0K | $-158.0K | |
| Debt Issued | · | · | · | · | · | $14M | · | · | |
| Net Debt Issued | · | · | · | $-6M | · | $14M | · | · | |
| Financing Cash Flow | $121M | $61M | $-8M | $111M | $21M | $17M | $73M | $4M | |
| Net Change in Cash | $-15M | $2M | $20M | $-24M | $-8M | $-12M | $50M | $-15M | |
| Taxes Paid | $-33.0K | $-32.0K | · | · | · | · | · | · | |
| Free Cash Flow | $-42M | $-38M | $-32M | $-28M | · | $-29M | $-23M | · | |
| Levered FCF | · | · | $-32M | $-29M | · | $-29M | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -28.1% | -47.8% | -27.4% | -36.1% | -79.3% | -61.2% | -73.9% | · | |
| ROE | -22.4% | -60.4% | -33.8% | -26.8% | -238.5% | -104.2% | -45.2% | · | |
| ROIC | -26.9% | -51.7% | -41.0% | -27.8% | -190.1% | -119.0% | -48.8% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 | 8.3 | 11.5 | · | |
| Quick Ratio | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 | 8.1 | 11.0 | · | |
| Interest Coverage | · | · | -86.8 | -25.7 | -27.0 | -71.2 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.43 | $1.06 | $1.21 | $1.79 | $0.60 | $1.47 | $3.06 | · | |
| Cash Flow / Share | $-0.31 | $-0.38 | $-0.32 | $-0.44 | · | · | · | · | |
| Cash / Share | $0.15 | $0.36 | $0.47 | $0.21 | $1.29 | $2.43 | $3.21 | · | |
| EPS (TTM) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | · | |
| Market Cap | $1.61B | $386M | $92M | $116M | $22M | $45M | $67M | · | |
| P/E | -39.1 | -8.8 | -4.6 | -4.3 | -0.5 | · | · | · | |
| P/B | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | 1.2 | · | |
| P / Tangible Book | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | · | · | |
| P / Cash Flow | -38.2 | -10.1 | -2.9 | -4.1 | -0.8 | -1.5 | -2.9 | · | |
| P / FCF | -38.2 | -10.1 | -2.9 | -4.1 | · | -1.5 | -2.9 | · | |
| Earnings Yield | -2.6% | -11.4% | -21.6% | -23.3% | -190.5% | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $10M | $6M | $10M | $9M | $8M | $9M | $11M | $10M | $9M | $7M | $6M | $6M | $5M | $4M | $6M | |
| SG&A Expense | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | |
| Operating Expenses | $21M | $15M | $10M | $14M | $14M | $11M | $12M | $14M | $13M | $12M | $9M | $9M | $8M | $8M | $7M | $8M | |
| Operating Income | $-21M | $-15M | $-10M | $-14M | $-14M | $-11M | $-12M | $-14M | $-13M | $-12M | $-9M | $-9M | $-8M | $-8M | $-7M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1.0K | $1.0K | · | $3.0K | $153.0K | $231.0K | $274.0K | $292.0K | |
| Interest Income | $3M | $2M | $2M | $2M | $1M | $1M | $843.0K | $826.0K | $935.0K | $998.0K | $1M | $1M | · | · | · | · | |
| Other Non-op | $-3.0K | $4.0K | $-16.0K | $-2.0K | $-7.0K | $-6.0K | $2.0K | $-11.0K | $-5.0K | $-1.0K | $-3.0K | $154.0K | $153.0K | $165.0K | $702.0K | $132.0K | |
| Pretax Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| Income Tax | $-19.0K | $-20.0K | $-17.0K | $-15.0K | $-21.0K | $-11.0K | $17.0K | $-31.0K | $-8.0K | $-8.0K | $18.0K | $-13.0K | $-30.0K | $-7.0K | $-20.0K | $-7.0K | |
| Net Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| EPS (Basic) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| EPS (Diluted) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| Shares (Basic) | 156,602,158 | 145,592,901 | · | 145,104,986 | 130,350,391 | 117,610,750 | · | 101,282,228 | 101,041,573 | 99,517,212 | · | 99,325,540 | 98,698,579 | 98,610,671 | · | 68,898,810 | |
| Shares (Diluted) | 156,602,158 | 145,592,901 | · | 145,104,986 | 130,350,391 | 117,610,750 | · | 101,282,228 | 101,041,573 | 99,517,212 | · | 99,325,540 | 98,698,579 | 98,610,671 | · | 68,898,810 | |
| EBITDA | $-21M | $-15M | · | $-14M | $-14M | $-11M | · | $-14M | $-13M | $-12M | · | $-9M | $-8M | $-8M | · | $-8M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $19M | $19M | $57M | $117M | $19M | $34M | $16M | $13M | $14M | $32M | $26M | $14M | $12M | $13M | $67M | |
| Short-term Investments | $265M | $152M | $169M | $138M | $87M | $84M | $74M | $49M | $57M | $59M | $51M | $63M | $80M | $100M | $108M | $59M | |
| Prepaid Expense | $4M | $2M | $1M | $1M | $2M | $2M | $939.0K | $1M | $2M | $3M | $4M | $4M | $3M | $1M | $795.0K | $1M | |
| Other Current Assets | $3M | $2M | $2M | $2M | $2M | $834.0K | $867.0K | $667.0K | $830.0K | $721.0K | $955.0K | $1M | $2M | $2M | $1M | $421.0K | |
| Current Assets | $326M | $176M | $192M | $198M | $207M | $106M | $109M | $67M | $72M | $77M | $88M | $94M | $99M | $114M | $123M | $127M | |
| PP&E (Net) | $336.0K | $265.0K | $178.0K | $213.0K | $239.0K | $277.0K | $157.0K | $174.0K | $198.0K | $204.0K | $216.0K | $238.0K | $225.0K | $245.0K | $170.0K | $68.0K | |
| PP&E (Gross) | · | · | $537.0K | · | · | · | $385.0K | · | · | · | $350.0K | · | · | · | $395.0K | · | |
| Accum. Depreciation | · | · | $359.0K | · | · | · | $228.0K | · | · | · | $134.0K | · | · | · | $225.0K | · | |
| Other Non-current Assets | $4M | $3M | $928.0K | $103.0K | $68.0K | $241.0K | $243.0K | $256.0K | $273.0K | $311.0K | $297.0K | $297.0K | $68.0K | $225.0K | $205.0K | $922.0K | |
| Total Assets | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Accounts Payable | $3M | $2M | $4M | $3M | $3M | $1M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $3M | $2M | |
| Accrued Liabilities | $5M | $5M | $6M | $6M | $6M | $5M | $7M | $7M | $5M | $3M | $4M | $4M | $3M | $3M | $4M | $5M | |
| Current Liabilities | $9M | $7M | $10M | $9M | $9M | $7M | $11M | $9M | $7M | $5M | $6M | $5M | $5M | $13M | $13M | $15M | |
| Capital Leases | $276.0K | $364.0K | $446.0K | $527.0K | $605.0K | $681.0K | $747.0K | $816.0K | $884.0K | $949.0K | $1M | $1M | $1M | $1M | $2.0K | $2.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.0K | $15.0K | |
| Total Liabilities | $9M | $7M | $10M | $10M | $10M | $8M | $11M | $10M | $8M | $6M | $7M | $6M | $6M | $14M | $16M | $18M | |
| Common Stock | $142.0K | $128.0K | $128.0K | $128.0K | $122.0K | $100.0K | $94.0K | $75.0K | $73.0K | $69.0K | $68.0K | $64.0K | $63.0K | $60.0K | $60.0K | $58.0K | |
| Paid-in Capital | $683M | $515M | $513M | $511M | $508M | $397M | $387M | $334M | $329M | $322M | $322M | $321M | $319M | $318M | $318M | $315M | |
| Retained Earnings | $-361M | $-343M | $-330M | $-321M | $-310M | $-297M | $-287M | $-276M | $-262M | $-250M | $-239M | $-231M | $-224M | $-216M | $-210M | $-205M | |
| AOCI | $-425.0K | $-190.0K | $148.0K | $30.0K | $24.0K | $73.0K | $61.0K | $139.0K | $-84.0K | $-67.0K | $-29.0K | $-217.0K | $-248.0K | $-88.0K | $-122.0K | $-263.0K | |
| Stockholders' Equity | $322M | $172M | $183M | $190M | $198M | $99M | $100M | $59M | $66M | $72M | $83M | $90M | $95M | $102M | $107M | $110M | |
| Liabilities + Equity | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Shares Outstanding | 142,420,883 | 128,411,048 | 128,306,056 | 128,215,113 | 121,775,753 | 99,892,915 | 93,602,631 | 75,454,375 | 72,591,917 | 68,960,167 | 68,283,699 | 63,855,330 | 63,098,455 | 60,065,408 | 59,943,430 | 58,322,517 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $34.0K | $31.0K | $38.0K | $38.0K | $37.0K | $38.0K | $36.0K | $38.0K | $35.0K | $35.0K | $35.0K | $34.0K | $19.0K | $15.0K | $9.0K | |
| Stock-based Comp | $3M | $2M | $1M | $1M | $1M | $1M | $916.0K | $822.0K | $1M | $723.0K | $609.0K | $530.0K | $530.0K | $578.0K | $501.0K | $569.0K | |
| Other Non-cash | · | $-6M | · | · | · | $-4M | · | · | · | $-323.0K | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-17M | $-17M | $-8M | $-11M | $-10M | $-13M | $-10M | $-10M | $-9M | $-10M | $-6M | $-7M | $-10M | $-8M | $-6M | $-9M | |
| CapEx | $124.0K | $102.0K | $0 | $12.0K | · | · | $7.0K | $0 | · | · | $22.0K | $18.0K | $40.0K | $57.0K | $116.0K | · | |
| Investing Cash Flow | $-112M | $17M | $-31M | $-51M | $-3M | $-10M | $-24M | $8M | $3M | $-8M | $13M | $18M | $20M | $9M | $-48M | $-5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Financing Cash Flow | $164M | $222.0K | $284.0K | $2M | $110M | $9M | $51M | $5M | $5M | $-28.0K | $-54.0K | $2M | $-8M | $-2M | $652.0K | $55M | |
| Net Change in Cash | $35M | $498.0K | $-38M | $-60M | $98M | $-15M | $18M | $3M | $-848.0K | $-19M | $6M | $12M | $2M | $-938.0K | $-54M | $42M | |
| Free Cash Flow | · | $-17M | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -6.6% | -9.2% | · | -8.8% | -8.7% | -11.1% | · | -16.1% | -14.1% | -11.2% | · | -6.9% | -7.8% | -8.7% | · | -10.3% | |
| ROE | -6.9% | -9.7% | · | -9.5% | -9.3% | -12.0% | · | -17.8% | -15.3% | -12.5% | · | -7.7% | -9.2% | -11.4% | · | -13.6% | |
| ROIC | -6.4% | -8.6% | · | -7.3% | -6.9% | -11.5% | · | -23.8% | -20.1% | -16.4% | · | -10.1% | -8.8% | -7.4% | · | -7.6% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 37.3 | 24.8 | · | 21.9 | 22.4 | 15.4 | · | 7.4 | 10.7 | 14.6 | · | 18.2 | 21.1 | 8.7 | · | 8.7 | |
| Quick Ratio | 36.5 | 24.1 | · | 21.6 | 22.1 | 15.0 | · | 7.2 | 10.3 | 13.8 | · | 17.2 | 20.0 | 8.4 | · | 8.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -13289.0 | -11906.0 | · | -3015.0 | -54.8 | -32.7 | · | -28.8 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.26 | $1.34 | · | $1.48 | $1.63 | $1.00 | · | $0.78 | $0.91 | $1.05 | · | $1.40 | $1.51 | $1.69 | · | $1.88 | |
| Cash Flow / Share | · | $-0.11 | · | · | · | $-0.11 | · | · | · | $-0.11 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.38 | $0.15 | · | $0.44 | $0.96 | $0.19 | · | $0.21 | $0.18 | $0.20 | · | $0.41 | $0.22 | $0.19 | · | $1.14 | |
| EPS (TTM) | $-0.34 | $-0.32 | · | $-0.37 | $-0.42 | $-0.45 | · | $-0.44 | $-0.39 | $-0.34 | · | $-0.16 | $-0.20 | $-0.27 | · | $-0.74 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-51M | $-46M | · | $-46M | $-47M | $-47M | · | $-44M | $-39M | $-34M | · | $-27M | $-27M | $-28M | · | $-32M | |
| Market Cap | $2.66B | $1.53B | · | $1.17B | $666M | $628M | · | $252M | $216M | $238M | · | $139M | $151M | $111M | · | $90M | |
| P/E | -54.9 | -37.3 | · | -24.7 | -13.0 | -14.0 | · | -7.6 | -7.6 | -10.1 | · | -13.6 | -11.9 | -6.9 | · | -2.1 | |
| P/B | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Tangible Book | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Cash Flow | · | -91.8 | · | · | · | -46.6 | · | · | · | -22.7 | · | · | · | -13.6 | · | · | |
| Earnings Yield | -1.8% | -2.7% | · | -4.0% | -7.7% | -7.1% | · | -13.2% | -13.1% | -9.9% | · | -7.3% | -8.4% | -14.6% | · | -48.0% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utile netto | $-43M | $-48M | $-29M | $-29M | $-34M |
| EPS Diluito | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 |
| Quick Ratio | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-42M | $-38M | $-32M | $-28M | · |
Proprietari istituzionali (13F) 226 filer · $2.8B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
226
Valore detenuto
$2.8B
Nuove posizioni
41
Posizioni chiuse
19
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 41 (-2 vs trimestre precedente) | 19 (-5 vs trimestre precedente) | 89 (+23 vs trimestre precedente) | 61 (-4 vs trimestre precedente) | +13.7M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| NEA Management Company, LLC | $246.594.552 | 13.222.228 | 8,67% | Azioni |
| FMR LLC | $234.296.949 | 12.562.839 | 8,24% | Azioni |
| BlackRock, Inc. | $208.041.234 | 11.155.026 | 7,32% | Azioni |
| Frazier Life Sciences Management, L.P. | $185.370.687 | 9.939.447 | 6,52% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $106.017.642 | 5.684.592 | 3,73% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $103.147.089 | 5.530.675 | 3,63% | Azioni |
| Vivo Capital, LLC | $95.015.558 | 5.094.668 | 3,34% | Azioni |
| VANGUARD GROUP INC | $80.561.880 | 6.434.655 | 2,83% | Azioni |
| Woodline Partners LP | $76.116.860 | 4.081.333 | 2,68% | Azioni |
| Vestal Point Capital, LP | $57.815.000 | 3.100.000 | 2,03% | Azioni |
| MPM BIOIMPACT LLC | $57.322.211 | 3.073.577 | 2,02% | Azioni |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $57.269.301 | 3.070.740 | 2,01% | Azioni |
| STATE STREET CORP | $56.459.425 | 3.027.315 | 1,99% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $54.619.528 | 2.928.068 | 1,92% | Azioni |
| MARSHALL WACE, LLP | $49.872.655 | 2.674.137 | 1,75% | Azioni |
| EVENTIDE ASSET MANAGEMENT, LLC | $49.609.000 | 2.660.000 | 1,74% | Azioni |
| Rubric Capital Management LP | $46.709.167 | 2.504.513 | 1,64% | Azioni |
| Artia Global Partners LP | $41.232.390 | 2.210.852 | 1,45% | Azioni |
| ACORN CAPITAL ADVISORS, LLC | $40.001.341 | 2.144.844 | 1,41% | Azioni |
| First Light Asset Management, LLC | $39.113.060 | 2.097.215 | 1,38% | Azioni |
| Pictet Asset Management Holding SA | $37.557.109 | 2.013.786 | 1,32% | Azioni |
| Logos Global Management LP | $35.062.000 | 1.880.000 | 1,23% | Azioni |
| Affinity Asset Advisors, LLC | $33.573.208 | 1.800.172 | 1,18% | Azioni |
| EMERALD ADVISERS, LLC | $33.525.445 | 1.797.611 | 1,18% | Azioni |
| Siren, L.L.C. | $33.325.070 | 1.786.867 | 1,17% | Azioni |
| Pivotal bioVenture Partners Investment Advisor LLC | $32.500.833 | 1.742.672 | 1,14% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $30.038.753 | 1.610.657 | 1,06% | Azioni |
| VIKING GLOBAL INVESTORS LP | $28.807.611 | 1.544.644 | 1,01% | Azioni |
| BANK OF AMERICA CORP /DE/ | $28.588.381 | 1.532.889 | 1,01% | Azioni |
| Assenagon Asset Management S.A. | $28.447.106 | 1.525.314 | 1,00% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $28.100.554 | 2.355.453 | 0,99% | Azioni |
| ORBIMED ADVISORS LLC | $26.674.964 | 1.430.293 | 0,94% | Azioni |
| Jones Hill Capital LP | $24.976.304 | 1.339.212 | 0,88% | Azioni |
| NAN FUNG TRINITY (HK) LTD | $22.634.013 | 1.213.620 | 0,80% | Azioni |
| EMERALD MUTUAL FUND ADVISERS TRUST | $22.584.497 | 1.210.965 | 0,79% | Azioni |
| GOLDMAN SACHS GROUP INC | $22.426.998 | 1.202.520 | 0,79% | Azioni |
| Soleus Capital Management, L.P. | $21.999.876 | 1.179.618 | 0,77% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $21.948.663 | 1.176.872 | 0,77% | Azioni |
| BARCLAYS PLC | $21.299.737 | 1.142.077 | 0,75% | Azioni |
| Saturn V Capital Management LP | $19.620.602 | 1.052.043 | 0,69% | Azioni |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $19.359.763 | 1.038.057 | 0,68% | Azioni |
| NORTHERN TRUST CORP | $18.762.609 | 1.006.038 | 0,66% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.138.990 | 972.600 | 0,64% | Opzione Call |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $18.004.747 | 965.402 | 0,63% | Azioni |
| Candriam S.C.A. | $18.002.647 | 966.219 | 0,63% | Azioni |
| Balyasny Asset Management L.P. | $15.760.873 | 845.087 | 0,55% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $15.685.750 | 841.059 | 0,55% | Azioni |
| MORGAN STANLEY | $14.928.673 | 800.465 | 0,53% | Azioni |
| Nuveen, LLC | $14.270.533 | 765.176 | 0,50% | Azioni |
| Burkehill Global Management, LP | $13.521.250 | 725.000 | 0,48% | Azioni |
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×10 depositi | 07 Maggio 2026 | 10,50% | Modifica | Investimento passivo | SEC |
| Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd., Richard J. Lim, Claudio Nessi, Anne-Mari Paster, Otello Stampacchia | 20 Maggio 2019 | · | Deposito iniziale | Campagna per il consiglio di amministrazione | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 37 insider · 13 dirigenti · 9 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jennifer L Good | President & CEO | 19 Febbraio 2026 A | 213.313 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 08 Gennaio 2026 A | · | 0 | 0 | $0 |
| Lisa Delfini | Chief Financial Officer | 31 Maggio 2025 A | 64.660 | 0 | 0 | $0 |
| Christopher Seiter | Chief Financial Officer | 17 Febbraio 2021 A | · | 0 | 0 | $0 |
| Farrell Simon | Chief Commercial Officer | 19 Febbraio 2026 A | 76.900 | 0 | 0 | $0 |
| Christopher Galletta | Controller and Principal Accounting Officer | 19 Febbraio 2026 A | 26.095 | 0 | 0 | $0 |
| James V Cassella | Chief Development Officer | 19 Febbraio 2026 A | · | 0 | 0 | $0 |
| Thomas Sciascia | Chief Scientific Officer | 19 Febbraio 2026 A | 221.373 | 0 | 0 | $0 |
| David J Clark | Chief Medical Officer | 15 Febbraio 2024 A | · | 0 | 0 | $0 |
| William P Forbes | Chief Development Officer | 29 Giugno 2022 A | · | 0 | 0 | $0 |
| Frank P Muscolo | Controller | 17 Febbraio 2021 A | · | 0 | 0 | $0 |
| Helena Brett-Smith | Chief Development Officer | 13 Febbraio 2020 A | · | 0 | 0 | $0 |
| Yann Mazabraud | Chief Commercial Officer and Head of International | 13 Febbraio 2020 A | · | 0 | 0 | $0 |
| Michael Thomas Heffernan | Direttore | 15 Settembre 2026 M | 6.351 | 0 | 4 | $-595.806 |
| David P Meeker | Direttore | 03 Giugno 2026 A | 352.489 | 0 | 0 | $0 |
| Edward T. Mathers | Direttore | 03 Giugno 2026 A | 948.948 | 0 | 0 | $0 |
| Dominick Colangelo | Direttore | 03 Giugno 2026 A | · | 0 | 0 | $0 |
| Anne Vanlent | Direttore | 03 Giugno 2026 A | 25.983 | 0 | 0 | $0 |
| Mette Kirstine Agger | Direttore | 09 Maggio 2019 C | 1.151.544 | 0 | 0 | $0 |
| Anna Guyer Mitsak | Direttore | 07 Maggio 2019 A | · | 0 | 0 | $0 |
| Eran Nadav | Direttore | 07 Maggio 2019 A | · | 0 | 0 | $0 |
| Mohamad Makhzoumi | Proprietario del 10% | 11 Aprile 2022 P | 948.948 | 0 | 0 | $0 |
| Ali Behbahani | Proprietario del 10% | 11 Aprile 2022 P | 948.948 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | Proprietario del 10% | 11 Aprile 2022 P | 948.948 | 0 | 0 | $0 |
| Peter W. Sonsini | Proprietario del 10% | 11 Aprile 2022 P | 948.948 | 0 | 0 | $0 |
| Paul Walker | Proprietario del 10% | 11 Aprile 2022 P | 948.948 | 0 | 0 | $0 |
| Forest Baskett | Proprietario del 10% | 11 Aprile 2022 P | 10.421.428 | 0 | 0 | $0 |
| Scott D. Sandell | Proprietario del 10% | 11 Aprile 2022 P | 948.948 | 0 | 0 | $0 |
| Joshua Makower | Proprietario del 10% | 03 Aprile 2020 X | 5.937.998 | 0 | 0 | $0 |
| Debra A Drake | Proprietario del 10% | 09 Maggio 2019 C | 10.399 | 0 | 0 | $0 |
| Richard King Mellon Foundation | Proprietario del 10% | 09 Maggio 2019 C | 347.157 | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | Proprietario del 10% | 09 Maggio 2019 C | 1.151.544 | 0 | 0 | $0 |
| Peter F Drake | Proprietario del 10% | 09 Maggio 2019 C | 62.540 | 0 | 0 | $0 |
| William J Oshea | Proprietario del 10% | 09 Maggio 2019 C | 114.080 | 0 | 0 | $0 |
| David M Mott | Proprietario del 10% | 09 Maggio 2019 C | 4.438.562 | 0 | 0 | $0 |
| Peter J Barris | Proprietario del 10% | 09 Maggio 2019 C | 4.438.562 | 0 | 0 | $0 |
| Carmen Chang | · | 11 Aprile 2022 P | 948.948 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 23 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,55% | 17.529 NS | 31 Luglio 2026 | N-PORT |
| IHE · iShares Trust | 0,43% | 436.183 SH | 11 Settembre 2026 | Giornaliero |
| VFMO · VANGUARD WELLINGTON FUND | 0,14% | 148.479 SH | 19 Agosto 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 10.058 SH | 02 Ottobre 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,12% | 114.901 SH | 19 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | 0,11% | 1.007.147 SH | 11 Settembre 2026 | Giornaliero |
| IBB · iShares Trust | 0,11% | 707.885 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,06% | 51.308 NS | 31 Luglio 2026 | N-PORT |
| ISCG · iShares Trust | 0,06% | 37.734 SH | 11 Settembre 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 616.796 SH | 19 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,06% | 2.737.721 SH | 11 Settembre 2026 | Giornaliero |
| ESML · iShares Trust | 0,05% | 81.532 SH | 11 Settembre 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,03% | 287.822 SH | 19 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 45.551 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.352.952 SH | 19 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | 0,01% | 5.214 SH | 11 Settembre 2026 | Giornaliero |
| TILT · FlexShares Trust | 0,00% | 3.318 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 152.436 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 24.754 SH | 09 Settembre 2026 | Giornaliero |
| PTH · Invesco Exchange-Traded Fund Trust | 0,00% | 25 SH | 02 Ottobre 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.048.595 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 8.874 SH | 19 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | · | 5.335 SH | 11 Settembre 2026 | Giornaliero |
TRVI Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 18 analisti
COMPRA
Target mediano
$25.00
+81,4%
6 33,3%
Acquisto forte
11 61,1%
Compra
1 5,6%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
11 analisti · 2026-10-04Target medio $28.18 +104,5%
← Sotto tutti i target
Prezzo attuale $13.78
Basso$23.00
Media$28.18
Alto$40.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| ETON | $457M | · | 104.9% | -5.8% | -18.4% | 53.5% |
| RAPP | $1.45B | -10.6 | · | · | -29.8% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 6, 2026